CD274 and neoplasm: For example, studies have shown that neutralizing bispecific antibodies targeting both PD-L1 and CD 3 (cluster of differentiation 3) can reverse T cell suppression mediated by tumor-derived exosomes in vivo, enhancing their migration and anti-tumor activity.